Proposed Fundraise and Capital Access Window

UPON PUBLICATION OF THIS ANNOUNCEMENT, THE INSIDE INFORMATION CONTAINED HEREIN IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Verici Dx plc

(“Verici Dx” or the “Company”)

Proposed Fundraise and Capital Access Window

Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces its intention to undertake a proposed equity fundraising with institutional and other investors (the “Proposed Fundraise”).

The Proposed Fundraise is being conducted by Singer Capital Markets and Oberon Investments as joint bookrunners and brokers to the Company.

The Company has elected to utilise AIM's Capital Access Window in connection with the Proposed Fundraise. Accordingly, trading in the Company's Ordinary Shares on AIM will enter a Capital Access Window with effect from 7.30 a.m. on 1 October 2026 and trading will remain paused until a further announcement is made regarding the outcome of the Proposed Fundraise.

The price at which the new Ordinary Shares will be issued and the final number of new Ordinary Shares to be issued pursuant to the Proposed Fundraise will be determined following completion of the bookbuild. The Company will announce the results of the Proposed Fundraise as soon as practicable following completion of the bookbuild.

Proposed Fundraising

As stated at the time, the fundraise in June 2026 has provided the Company with sufficient funding to expand the commercial team, targeted marketing expenditure and to provide further working capital. The Proposed Fundraise will enable the Company to maintain these growth plans. The Board has been greatly encouraged by the support expressed from certain key shareholders to date for the Proposed Fundraise and the Company will update Shareholders with further details shortly.

Interim results

Separately today, the Company has announced its unaudited interim results for the six months ended 30 June 2026 (the "Interim Results”). Investors are encouraged to read the Interim Results in conjunction with this announcement.

Capital Access Window

Following the changes to the AIM Rules for Companies which took effect on 5 August 2026, the Company has elected to utilise the Capital Access Window in connection with the Proposed Fundraise. The new provisions permit AIM companies undertaking an equity fundraising to request a temporary pause in trading while the transaction is being negotiated or marketed.

The Board believes that use of the Capital Access Window is appropriate in connection with the Proposed Fundraise to provide pricing stability while the bookbuild is undertaken and facilitates engagement with a broad range of potential investors.